UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oestrogen receptor-α contributes to the regulation of the hedgehog signalling pathway in ERα-positive gastric cancer

British journal of cancer, 2010-01, Vol.102 (4), p.738-747

2010

Volltextzugriff (PDF)

Nuclear Factor-κB p65 (RelA) Transcription Factor Is Constitutively Activated in Human Gastric Carcinoma Tissue

Clinical cancer research, 2001-12, Vol.7 (12), p.4136-4142

2001

Volltextzugriff (PDF)

Hedgehog signaling pathway as a therapeutic target in breast cancer

Cancer letters, 2005-09, Vol.227 (2), p.99-104

Katano, Mitsuo

2005

Volltextzugriff (PDF)

Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer

Cancer research (Chicago, Ill.), 2004-09, Vol.64 (17), p.6071-6074

2004

Volltextzugriff (PDF)

Cancer Immunotherapy Using NKG2D and DNAM-1 Systems

Anticancer research, 2012-06, Vol.32 (6), p.2241-2247

2012

Volltextzugriff (PDF)

The Contribution of Vascular Endothelial Growth Factor to the Induction of Regulatory T-Cells in Malignant Effusions

Anticancer research, 2009-03, Vol.29 (3), p.881-888

2009

Volltextzugriff (PDF)

Purification, Characterization and Biological Significance of Tumor-derived Exosomes

Anticancer research, 2005-11, Vol.25 (6A), p.3703-3707

2005

Volltextzugriff (PDF)

Immunotherapy Approaches Targeting Regulatory T-Cells

Anticancer research, 2012-03, Vol.32 (3), p.997-1003

2012

Volltextzugriff (PDF)

Combining Cetuximab with Killer Lymphocytes Synergistically Inhibits Human Cholangiocarcinoma Cells In Vitro

Anticancer research, 2012-06, Vol.32 (6), p.2249-2256

2012

Volltextzugriff (PDF)

Combinatorial Cytotoxicity of Gemcitabine and Cytokine-activated Killer Cells in Hepatocellular Carcinoma via the NKG2D-MICA/B System

Anticancer research, 2011-07, Vol.31 (7), p.2505-2510

2011

Volltextzugriff (PDF)

Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of Shh

Cancer Immunology, Immunotherapy, 2010-05, Vol.59 (5), p.675-686

2010

Volltextzugriff (PDF)

Recent Advances and Challenges in Stereotactic Body Radiotherapy

Technology in cancer research & treatment, 2024-01, Vol.23, p.15330338241229363-15330338241229363

2024

Volltextzugriff (PDF)

Induction of Cytotoxic T Lymphocytes by CEA Peptide-pulsed gamma delta T-Cells Isolated from Patients with Advanced Cancer

Anticancer research, 2011-07, Vol.31 (7), p.2419-2424

2011

Volltextzugriff (PDF)

Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-κB activation

Oncogene, 2000-02, Vol.19 (9), p.1225-1231

2000

Volltextzugriff (PDF)

Long-term Outcome of Immunotherapy for Patients with Refractory Pancreatic Cancer

Anticancer research, 2009-03, Vol.29 (3), p.831-836

2009

Volltextzugriff (PDF)

A New Method for Rapid Cytotoxic T-lymphocyte Induction Using a Multiple Cytokine Cocktail

Anticancer research, 2012-06, Vol.32 (6), p.2385-2390

2012

Volltextzugriff (PDF)

Long-term Vaccine Therapy with Autologous Whole Tumor Cell-pulsed Dendritic Cells for a Patient with Recurrent Rectal Carcinoma

Anticancer research, 2011-11, Vol.31 (11), p.3995-4005

2011

Volltextzugriff (PDF)

Novel link between estrogen receptor alpha and hedgehog pathway in breast cancer

Anticancer research, 2008-03, Vol.28 (2A), p.731-740

2008

Volltextzugriff (PDF)

Regulatory T-Cells Are Possible Effect Prediction Markers of Immunotherapy for Cancer Patients

Anticancer research, 2008-07, Vol.28 (4C), p.2401-2408

2008

Volltextzugriff (PDF)

Hepatocyte growth factor production by peripheral blood mononuclear cells of recurrent cancer patients

Anticancer research, 2001-05, Vol.21 (3C), p.2195

2001

Volltextzugriff (PDF)

Cyclosporin-A Enhances Docetaxel-Induced Apoptosis through Inhibition of Nuclear Factor-κB Activation in Human Gastric Carcinoma Cells

Clinical cancer research, 2003-11, Vol.9 (14), p.5409-5416

2003

Volltextzugriff (PDF)

Psk-mediated NF-κb inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1

Oncogene, 2003-04, Vol.22 (14), p.2088-2096

2003

Volltextzugriff (PDF)

Interleukin 1β Enhances Invasive Ability of Gastric Carcinoma through Nuclear Factor-κB Activation

Clinical cancer research, 2004-03, Vol.10 (5), p.1853-1859

2004

Volltextzugriff (PDF)

Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use

Cancer Immunology, Immunotherapy, 2003-09, Vol.52 (9), p.561-568

2003

Volltextzugriff (PDF)

The past, the present and future of the OK-432 therapy for patients with malignant effusions

Anticancer research, 1998-09, Vol.18 (5D), p.3917

1998

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(97)

Sprache

Englisch
(97)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(97)
Science & Technology
(97)
Humans
(80)
Biological And Medical Sciences
(74)
Medical Sciences
(70)
Tumors
(49)
Female
(42)
Male
(42)
Middle Aged
(29)
Aged
(27)
Adult
(23)
Gastroenterology. Liver. Pancreas. Abdomen
(22)
Antineoplastic Agents
(21)
Pharmacology. Drug Treatments
(21)
Animals
(16)
Aged, 80 And Over
(14)
Flow Cytometry
(13)
Prognosis
(13)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(13)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oestrogen receptor-α contributes to the regulation of the hedgehog signalling pathway in ERα-positive gastric cancer

Nuclear Factor-κB p65 (RelA) Transcription Factor Is Constitutively Activated in Human Gastric Carcinoma Tissue

Hedgehog signaling pathway as a therapeutic target in breast cancer

Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer

Cancer Immunotherapy Using NKG2D and DNAM-1 Systems

The Contribution of Vascular Endothelial Growth Factor to the Induction of Regulatory T-Cells in Malignant Effusions

Purification, Characterization and Biological Significance of Tumor-derived Exosomes

Immunotherapy Approaches Targeting Regulatory T-Cells

Combining Cetuximab with Killer Lymphocytes Synergistically Inhibits Human Cholangiocarcinoma Cells In Vitro

Combinatorial Cytotoxicity of Gemcitabine and Cytokine-activated Killer Cells in Hepatocellular Carcinoma via the NKG2D-MICA/B System

Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of Shh

Recent Advances and Challenges in Stereotactic Body Radiotherapy

Induction of Cytotoxic T Lymphocytes by CEA Peptide-pulsed gamma delta T-Cells Isolated from Patients with Advanced Cancer

Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-κB activation

Long-term Outcome of Immunotherapy for Patients with Refractory Pancreatic Cancer

A New Method for Rapid Cytotoxic T-lymphocyte Induction Using a Multiple Cytokine Cocktail

Long-term Vaccine Therapy with Autologous Whole Tumor Cell-pulsed Dendritic Cells for a Patient with Recurrent Rectal Carcinoma

Novel link between estrogen receptor alpha and hedgehog pathway in breast cancer

Regulatory T-Cells Are Possible Effect Prediction Markers of Immunotherapy for Cancer Patients

Hepatocyte growth factor production by peripheral blood mononuclear cells of recurrent cancer patients

Cyclosporin-A Enhances Docetaxel-Induced Apoptosis through Inhibition of Nuclear Factor-κB Activation in Human Gastric Carcinoma Cells

Psk-mediated NF-κb inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1

Interleukin 1β Enhances Invasive Ability of Gastric Carcinoma through Nuclear Factor-κB Activation

Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use

The past, the present and future of the OK-432 therapy for patients with malignant effusions

Aktive Filter

Suchergebnisse filtern